Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Wagner

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Bone Marrow Transplantation|August 18, 2009
Donor CD4 T cells convert mixed to full donor T-cell chimerism and replenish the CD52-positive T-cell pool after alemtuzumab-based T-cell-depleted allo-transplantationR G Meyer, E M Wagner, A Konur, et al.
Leukemia|July 29, 2017
Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)G Bug, A Burchert, E-M Wagner, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 21, 2021
Current practice in nutrition after allogeneic hematopoietic stem cell transplantation - Results from a survey among hematopoietic stem cell transplant centersR Toenges, H Greinix, A Lawitschka, et al.
Mucosal Immunology|May 23, 2014
Foxp3+ regulatory T cells promote lung epithelial proliferationJ R Mock, B T Garibaldi, N R Aggarwal, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Bone Marrow Transplantation|August 18, 2009
Donor CD4 T cells convert mixed to full donor T-cell chimerism and replenish the CD52-positive T-cell pool after alemtuzumab-based T-cell-depleted allo-transplantationR G Meyer, E M Wagner, A Konur, et al.
Leukemia|July 29, 2017
Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)G Bug, A Burchert, E-M Wagner, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 21, 2021
Current practice in nutrition after allogeneic hematopoietic stem cell transplantation - Results from a survey among hematopoietic stem cell transplant centersR Toenges, H Greinix, A Lawitschka, et al.
Mucosal Immunology|May 23, 2014
Foxp3+ regulatory T cells promote lung epithelial proliferationJ R Mock, B T Garibaldi, N R Aggarwal, et al.
Pageof 9